logo
logo

Dosespot Announces Growth Investment From Psg

Jan 26, 2022•over 3 years ago
Dedham

Description

DoseSpot, a software-as-a-service (SaaS) platform that enables clinicians to electronically write and transmit prescriptions to pharmacies, today announced that they have partnered with PSG, a leading growth equity firm partnering with middle-market software and technology-enabled services companies. PSG’s investment will seek to accelerate DoseSpot’s ability to increase its support for existing and new customers, as well as enable a go-to-market strategy to expand its user base. Financial terms were not disclosed.

Company Information

Company

Dose Spot

Location

Dedham, Iowa, United States

About

DoseSpot is a Surescripts™ certified e-prescribing platform specifically designed to integrate with electronic health records, dental practice management systems, and digital health platforms. DoseSpot is certified to e-prescribe controlled substances and currently processes approximately one out of every 80 prescriptions in the United States. DoseSpot has provided e-prescribing solutions to the healthcare industry since 2009. For more information, please visit www.DoseSpot.com.